TY - JOUR
T1 - Quality assurance of computer-aided detection and diagnosis in colonoscopy
AU - Vinsard, Daniela Guerrero
AU - Mori, Yuichi
AU - Misawa, Masashi
AU - Kudo, Shin ei
AU - Rastogi, Amit
AU - Bagci, Ulas
AU - Rex, Douglas K.
AU - Wallace, Michael B.
N1 - Funding Information:
DISCLOSURE: A. Rastogi is a consultant for Olympus Corp, Boston Scientific, and Cook Endoscopy and received grant support from Olympus . D. Rex is a consultant for Olympus, Boston Scientific, Ferring Pharmaceuticals, Salix Pharmaceuticals, Aries Pharmaceuticals, and Medtronic. He has ownership in Satis Corporation and received research support from EndoAid , Medivators , and Olympus . M. Wallace is a consultant for Olympus and received grant support from Boston Scientific , Olympus , Medtronic , and Cosmo Pharmaceuticals . All other authors disclosed no financial relationships relevant to this publication.
Funding Information:
DISCLOSURE: A. Rastogi is a consultant for Olympus Corp, Boston Scientific, and Cook Endoscopy and received grant support from Olympus. D. Rex is a consultant for Olympus, Boston Scientific, Ferring Pharmaceuticals, Salix Pharmaceuticals, Aries Pharmaceuticals, and Medtronic. He has ownership in Satis Corporation and received research support from EndoAid, Medivators, and Olympus. M. Wallace is a consultant for Olympus and received grant support from Boston Scientific, Olympus, Medtronic, and Cosmo Pharmaceuticals. All other authors disclosed no financial relationships relevant to this publication.
Publisher Copyright:
© 2019 American Society for Gastrointestinal Endoscopy
PY - 2019/7
Y1 - 2019/7
N2 - Recent breakthroughs in artificial intelligence (AI), specifically via its emerging sub-field “deep learning,” have direct implications for computer-aided detection and diagnosis (CADe and/or CADx) for colonoscopy. AI is expected to have at least 2 major roles in colonoscopy practice—polyp detection (CADe) and polyp characterization (CADx). CADe has the potential to decrease the polyp miss rate, contributing to improving adenoma detection, whereas CADx can improve the accuracy of colorectal polyp optical diagnosis, leading to reduction of unnecessary polypectomy of non-neoplastic lesions, potential implementation of a resect-and-discard paradigm, and proper application of advanced resection techniques. A growing number of medical-engineering researchers are developing both CADe and CADx systems, some of which allow real-time recognition of polyps or in vivo identification of adenomas, with over 90% accuracy. However, the quality of the developed AI systems as well as that of the study designs vary significantly, hence raising some concerns regarding the generalization of the proposed AI systems. Initial studies were conducted in an exploratory or retrospective fashion by using stored images and likely overestimating the results. These drawbacks potentially hinder smooth implementation of this novel technology into colonoscopy practice. The aim of this article is to review both contributions and limitations in recent machine-learning-based CADe and/or CADx colonoscopy studies and propose some principles that should underlie system development and clinical testing.
AB - Recent breakthroughs in artificial intelligence (AI), specifically via its emerging sub-field “deep learning,” have direct implications for computer-aided detection and diagnosis (CADe and/or CADx) for colonoscopy. AI is expected to have at least 2 major roles in colonoscopy practice—polyp detection (CADe) and polyp characterization (CADx). CADe has the potential to decrease the polyp miss rate, contributing to improving adenoma detection, whereas CADx can improve the accuracy of colorectal polyp optical diagnosis, leading to reduction of unnecessary polypectomy of non-neoplastic lesions, potential implementation of a resect-and-discard paradigm, and proper application of advanced resection techniques. A growing number of medical-engineering researchers are developing both CADe and CADx systems, some of which allow real-time recognition of polyps or in vivo identification of adenomas, with over 90% accuracy. However, the quality of the developed AI systems as well as that of the study designs vary significantly, hence raising some concerns regarding the generalization of the proposed AI systems. Initial studies were conducted in an exploratory or retrospective fashion by using stored images and likely overestimating the results. These drawbacks potentially hinder smooth implementation of this novel technology into colonoscopy practice. The aim of this article is to review both contributions and limitations in recent machine-learning-based CADe and/or CADx colonoscopy studies and propose some principles that should underlie system development and clinical testing.
UR - http://www.scopus.com/inward/record.url?scp=85065917454&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85065917454&partnerID=8YFLogxK
U2 - 10.1016/j.gie.2019.03.019
DO - 10.1016/j.gie.2019.03.019
M3 - Review article
C2 - 30926431
AN - SCOPUS:85065917454
SN - 0016-5107
VL - 90
SP - 55
EP - 63
JO - Gastrointestinal endoscopy
JF - Gastrointestinal endoscopy
IS - 1
ER -